Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Microbiology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822018000200212 |
Resumo: | Abstract The evolution of microorganisms resistant to many medicines has become a major challenge for the scientific community around the world. Motivated by the gravity of such a situation, the World Health Organization released a report in 2014 with the aim of providing updated information on this critical scenario. Among the most worrying microorganisms, species from the genus Candida have exhibited a high rate of resistance to antifungal drugs. Therefore, the objective of this review is to show that the use of natural products (extracts or isolated biomolecules), along with conventional antifungal therapy, can be a very promising strategy to overcome microbial multiresistance. Some promising alternatives are essential oils of Melaleuca alternifolia (mainly composed of terpinen-4-ol, a type of monoterpene), lactoferrin (a peptide isolated from milk) and chitosan (a copolymer from chitin). Such products have great potential to increase antifungal therapy efficacy, mitigate side effects and provide a wide range of action in antifungal therapy. |
id |
SBM-1_ce549dbf9d286ff6f489a2ffeb92e5a8 |
---|---|
oai_identifier_str |
oai:scielo:S1517-83822018000200212 |
network_acronym_str |
SBM-1 |
network_name_str |
Brazilian Journal of Microbiology |
repository_id_str |
|
spelling |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatmentCandidaLactoferrinMelaleuca alternifoliaChitosanNatural productsAbstract The evolution of microorganisms resistant to many medicines has become a major challenge for the scientific community around the world. Motivated by the gravity of such a situation, the World Health Organization released a report in 2014 with the aim of providing updated information on this critical scenario. Among the most worrying microorganisms, species from the genus Candida have exhibited a high rate of resistance to antifungal drugs. Therefore, the objective of this review is to show that the use of natural products (extracts or isolated biomolecules), along with conventional antifungal therapy, can be a very promising strategy to overcome microbial multiresistance. Some promising alternatives are essential oils of Melaleuca alternifolia (mainly composed of terpinen-4-ol, a type of monoterpene), lactoferrin (a peptide isolated from milk) and chitosan (a copolymer from chitin). Such products have great potential to increase antifungal therapy efficacy, mitigate side effects and provide a wide range of action in antifungal therapy.Sociedade Brasileira de Microbiologia2018-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822018000200212Brazilian Journal of Microbiology v.49 n.2 2018reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1016/j.bjm.2017.05.008info:eu-repo/semantics/openAccessFelipe,Lorena de OliveiraSilva Júnior,Willer Ferreira daAraújo,Katialaine Corrêa deFabrino,Daniela Leiteeng2018-04-17T00:00:00Zoai:scielo:S1517-83822018000200212Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2018-04-17T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
title |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
spellingShingle |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment Felipe,Lorena de Oliveira Candida Lactoferrin Melaleuca alternifolia Chitosan Natural products |
title_short |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
title_full |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
title_fullStr |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
title_full_unstemmed |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
title_sort |
Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment |
author |
Felipe,Lorena de Oliveira |
author_facet |
Felipe,Lorena de Oliveira Silva Júnior,Willer Ferreira da Araújo,Katialaine Corrêa de Fabrino,Daniela Leite |
author_role |
author |
author2 |
Silva Júnior,Willer Ferreira da Araújo,Katialaine Corrêa de Fabrino,Daniela Leite |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Felipe,Lorena de Oliveira Silva Júnior,Willer Ferreira da Araújo,Katialaine Corrêa de Fabrino,Daniela Leite |
dc.subject.por.fl_str_mv |
Candida Lactoferrin Melaleuca alternifolia Chitosan Natural products |
topic |
Candida Lactoferrin Melaleuca alternifolia Chitosan Natural products |
description |
Abstract The evolution of microorganisms resistant to many medicines has become a major challenge for the scientific community around the world. Motivated by the gravity of such a situation, the World Health Organization released a report in 2014 with the aim of providing updated information on this critical scenario. Among the most worrying microorganisms, species from the genus Candida have exhibited a high rate of resistance to antifungal drugs. Therefore, the objective of this review is to show that the use of natural products (extracts or isolated biomolecules), along with conventional antifungal therapy, can be a very promising strategy to overcome microbial multiresistance. Some promising alternatives are essential oils of Melaleuca alternifolia (mainly composed of terpinen-4-ol, a type of monoterpene), lactoferrin (a peptide isolated from milk) and chitosan (a copolymer from chitin). Such products have great potential to increase antifungal therapy efficacy, mitigate side effects and provide a wide range of action in antifungal therapy. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822018000200212 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822018000200212 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjm.2017.05.008 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Microbiology v.49 n.2 2018 reponame:Brazilian Journal of Microbiology instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Brazilian Journal of Microbiology |
collection |
Brazilian Journal of Microbiology |
repository.name.fl_str_mv |
Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||mbmartin@usp.br |
_version_ |
1752122209331052544 |